M. Hanefeld & Sabine Fischer. 2000. Praktische Arzneitherapie. Praktische Arzneitherapie
459
503
.
Sharon Y. Kang & Vay Liang W. Go. (1999) PANCREATIC EXOCRINE-ENDOCRINE INTERRELATIONSHIP. Gastroenterology Clinics of North America 28:3, pages 551-569.
Crossref
Mitsuyoshi Yamamoto, Dong Mei Jia, Ken-Ichiro Fukumitsu, Issei Imoto, Yasuyuki Kihara, Yosihide Hirohata & Makoto Otsuki. (1999) Metabolic abnormalities in the genetically obese and diabetic Otsuka Long-Evans Tokushima fatty rat can be prevented and reversed by α-glucosidase inhibitor. Metabolism 48:3, pages 347-354.
Crossref
Odile Michel, Didier Heudes, Isabelle Lamarre, Carole Masurier, Marcelle Lavau, Jean Bariety, Jacques Chevalier, Marie-France Belair & Chantal Mandet. (1997) Reduction of insulin and triglycerides delays glomerulosclerosis in obese Zucker rats. Kidney International 52:6, pages 1532-1542.
Crossref
Kazuya Shinozaki, Masaaki Suzuki, Motoyoshi Ikebuchi, Junya Hirose, Yasushi Harano & Yutaka Harano. (1996) Improvement of insulin sensitivity and dyslipidemia with a new α-glucosidase inhibitor, voglibose, in nondiabetic hyperinsulinemic subjects. Metabolism 45:6, pages 731-737.
Crossref
. 1996.
181
214
.
E. Brendel & W. Wingender. 1996. Oral Antidiabetics. Oral Antidiabetics
611
632
.
M. Guslandi & P. C. BragaT. Wehrmann, B. Lembcke & W. F. Caspary. 1993. Drug-Induced Injury to the Digestive System. Drug-Induced Injury to the Digestive System
89
109
.
Werner Creutzfeldt & Michael Nauck. (2009) Gut hormones and diabetes mellitus. Diabetes/Metabolism Reviews 8:2, pages 149-177.
Crossref
Norio Fukase, Hideo Takahashi, Hideo Manaka, Masahiko Igarashi, Keiichi Yamatani, Makoto Daimon, Kazuhiko Sugiyama, Makoto Tominaga & Hideo Sasaki. (1992) Differences in glucagon-like peptide-1 and GIP responses following sucrose ingestion. Diabetes Research and Clinical Practice 15:3, pages 187-195.
Crossref
Ulrich R. Fölsch & Ulrich JungeUlrich R. Fölsch & Ulrich Junge. 1990. Medikamentöse Therapie in der Gastroenterologie. Medikamentöse Therapie in der Gastroenterologie
69
76
.
David JA Jenkins, Alexandra L. Jenkins, Thomas MS Wolever, Vladimir Vuksan, Furio Brighenti & Guilio Testolin. 1990. New Developments in Dietary Fiber. New Developments in Dietary Fiber
129
134
.
J.M. Brogard, B. Willemin, J.F. Blicklé, A.M. Lamalle & A. Stahl. (1989) Inhibiteurs des alpha-glucosidases: une nouvelle approche thérapeutique du diabète et des hypoglycémies fonctionnelles. La Revue de Médecine Interne 10:4, pages 365-374.
Crossref
D. J. A. Jenkins, A. L. Jenkins, Th. M. S. Wolever, V. Vuksan, G. S. Wong & R. G. Josse. 1989. Diabetes Mellitus: Pathophysiology and Therapy. Diabetes Mellitus: Pathophysiology and Therapy
299
308
.
W. F. Caspary. 1989. Diabetes Mellitus: Pathophysiology and Therapy. Diabetes Mellitus: Pathophysiology and Therapy
172
191
.
T. L. Peeters. 1989. Dietary Starches and Sugars in Man: A Comparison. Dietary Starches and Sugars in Man: A Comparison
119
133
.
Makoto Otsuki, Yoshinori Okabayashi, Atsushi Ohki, Itsuo Suehiro & Shigeaki Baba. (1988) Effect of α-glucosidase inhibitor on exocrine and endocrine pancreatic function in rats fed a high-carbohydrate diet consisting of sucrose or glucose. Diabetes Research and Clinical Practice 5:4, pages 257-263.
Crossref
B. Lembcke & W.F. Caspary. (1988) 6 Malabsorption syndromes. Baillière's Clinical Gastroenterology 2:2, pages 329-351.
Crossref
B. Lembcke. 1988. Acarbose for the Treatment of Diabetes Mellitus. Acarbose for the Treatment of Diabetes Mellitus
41
52
.
Michael B Bottorff, William E Evans, Ingrid Hillebrand, Bodo Junge, Lutz Müller, Walter Puls, Delf D Schmidt, Ernst Truscheit & Horst WillE. Truscheit, I. Hillebrand, B. Junge, L. Müller, W. Puls & D. Schmidt. 1988. Drug Concentration Monitoring Microbial Alpha-Glucosidase Inhibitors Plasminogen Activators. Drug Concentration Monitoring Microbial Alpha-Glucosidase Inhibitors Plasminogen Activators
17
99
.
I. Hillebrand. (2009) Pharmacological Modification of Digestion and Absorption. Diabetic Medicine 4:2, pages 147-150.
Crossref
L. O. Uttenthal, O. O. Ukponmwan, M. Ghiglione & S. R. Bloom. (1987) Acute and short term effects of intestinal alpha-glucosidase inhibition on gut hormone responses in man. Digestive Diseases and Sciences 32:2, pages 139-144.
Crossref
. (1986) XI. Bibliography. The Journal of Nutrition 116, pages S117-S149.
Crossref
E. SANDBERG, B. AHRÉN, D. TENDLER, M. CARLQUIST & S. EFENDIC. (2008)
Potentiation of glucose‐induced insulin secretion in the perfused rat pancreas by porcine GIP (gastric inhibitory polypeptide), bovine GIP, and bovine GIP
(139)
. Acta Physiologica Scandinavica 127:3, pages 323-326.
Crossref
W. Creutzfeldt & R. Ebert. (1985) New developments in the incretin concept. Diabetologia 28:8, pages 565-573.
Crossref
K O'Dea & J Turton. (1985) Optimum effectiveness of intestinal α-glucosidase inhibitors: Importance of uniform distribution through a meal. The American Journal of Clinical Nutrition 41:3, pages 511-516.
Crossref
M. Fritz, H. Kasper, J. Schrezenmeir & G. Siebert. (1985) Effect of Acarbose on the production of hydrogen and methane and on hormonal parameters in young adults under standardized low-fibre mixed diets. Zeitschrift für Ernährungswissenschaft 24:1, pages 1-18.
Crossref
Makoto Otsuki, Choitsu Sakamoto, Atsushi Ohki, Yoshinori Okabayashi, Hosoi Yuu, Mitsuo Maeda & Shigeaki Baba. (1983) Exocrine and endocrine pancreatic function in rats treated with α-glucosidase inhibitor (acarbose). Metabolism 32:8, pages 846-850.
Crossref
L. Okolicsanyi. 1983. Clinical Hepatology. Clinical Hepatology
70
77
.
Ulrich R. Fölsch & Ulrich JungeUlrich R. Fölsch & Ulrich Junge. 1982. Medikamentöse Therapie in der Gastroenterologie. Medikamentöse Therapie in der Gastroenterologie
55
64
.